TERNS PHARMACEUTICALS INCTERNS PHARMACEUTICALS INCTERNS PHARMACEUTICALS INC

TERNS PHARMACEUTICALS INC

No trades
See on Supercharts

Price target

13.160.00 0.00%
The 7 analysts offering 1 year price forecasts for 430 have a max estimate of — and a min estimate of —.

Analyst rating

Based on 8 analysts giving stock ratings to 430 in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

430 EPS for the last quarter is −0.28 EUR despite the estimation of −0.32 EUR. In the next quarter EPS is expected to reach −0.31 EUR. Track more of TERNS PHARMACEUTICALS INC financials and stay on top of what is up with the company.
In the next quarter TERNS PHARMACEUTICALS INC revenue is expected to reach 0 EUR. Check out TERNS PHARMACEUTICALS INC revenue and earnings and make informed decisions.
According to analysts, 430 price target is 13.16 EUR with a max estimate of 20.36 EUR and a min estimate of 5.09 EUR. Check if this forecast comes true in a year, meanwhile watch TERNS PHARMACEUTICALS INC stock price chart and keep track of the current situation with 430 news and stock market news.
We've gathered opinions of 8 analysts rating 430 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.